To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
GE Healthcare and BAC Announce Collaboration
GE Healthcare, a unit of General Electric Company and BAC BV, the Bio Affinity Company, have announced that they have entered into a strategic collaboration in the affinity ligand and chromatographic media area.
Under the terms of the agreement, the two companies will develop affinity chromatography media for human antibodies and adeno-associated virus (AAV) viral vector purification.
The first products are expected to be commercially available during 2007 through GE Healthcare’s Custom Designed Media business.
The collaboration is expected to generate several affinity chromatography media solutions for biopharmaceutical manufacture and drug discovery research.
"This collaboration will allow us to expand our current range of ligand technologies and libraries, enabling us to develop more efficient purification processes for our customers in biopharmaceutical manufacturing," said Ann O’Hara, General Manager of BioProcess for GE Healthcare.
"As a well established market leader, GE Healthcare is the perfect partner for us," said Dr. Laurens Sierkstra, CEO of BAC.
"This Agreement underlines their confidence in our CaptureSelect® products and clearly validates our technology as a giant step forward in the purification of pharmaceutical products."
